|
Biomerica, Inc. (BMRA) DCF -Bewertung
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Biomerica, Inc. (BMRA) Bundle
Sparen Sie Zeit und verbessern Sie die Genauigkeit mit unserem (BMRA) DCF -Taschenrechner! Mithilfe von realen Biomerica -Daten und anpassbaren Annahmen können Sie mit diesem Tool wie ein erfahrener Investor Biomerica, Inc. prognostizieren, analysieren und bewerten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.7 | 7.2 | 18.9 | 5.3 | 5.4 | 5.9 | 6.5 | 7.1 | 7.7 | 8.5 |
| Revenue Growth, % | 0 | 7.57 | 162.14 | -71.71 | 1.42 | 9.32 | 9.32 | 9.32 | 9.32 | 9.32 |
| EBITDA | -2.3 | -7.1 | -3.9 | -6.7 | -6.0 | -4.2 | -4.6 | -5.0 | -5.5 | -6.0 |
| EBITDA, % | -33.97 | -98.03 | -20.87 | -126.2 | -110.67 | -70.58 | -70.58 | -70.58 | -70.58 | -70.58 |
| Depreciation | .4 | .4 | .6 | .4 | .4 | .3 | .4 | .4 | .4 | .5 |
| Depreciation, % | 5.96 | 5.22 | 3.15 | 6.57 | 6.91 | 5.56 | 5.56 | 5.56 | 5.56 | 5.56 |
| EBIT | -2.7 | -7.4 | -4.5 | -7.1 | -6.4 | -4.3 | -4.7 | -5.1 | -5.6 | -6.2 |
| EBIT, % | -39.93 | -103.25 | -24.02 | -132.78 | -117.58 | -72.79 | -72.79 | -72.79 | -72.79 | -72.79 |
| Total Cash | 8.6 | 4.2 | 5.9 | 9.7 | 4.2 | 4.3 | 4.7 | 5.2 | 5.7 | 6.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.8 | 1.5 | .8 | .7 | .9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.4 |
| Account Receivables, % | 26.38 | 20.21 | 4.1 | 13.52 | 17.49 | 16.34 | 16.34 | 16.34 | 16.34 | 16.34 |
| Inventories | 2.9 | 3.2 | 2.4 | 2.1 | 2.4 | 2.2 | 2.4 | 2.6 | 2.8 | 3.1 |
| Inventories, % | 42.6 | 44.53 | 12.8 | 38.51 | 43.88 | 36.46 | 36.46 | 36.46 | 36.46 | 36.46 |
| Accounts Payable | .8 | .4 | .7 | .3 | .3 | .4 | .4 | .5 | .5 | .6 |
| Accounts Payable, % | 12.45 | 5.99 | 3.9 | 6.44 | 5.32 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 |
| Capital Expenditure | -.1 | -.3 | -.2 | -.1 | -.1 | -.1 | -.1 | -.1 | -.2 | -.2 |
| Capital Expenditure, % | -1.78 | -4.11 | -0.90261 | -1.46 | -2.12 | -2.07 | -2.07 | -2.07 | -2.07 | -2.07 |
| Tax Rate, % | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 |
| EBITAT | -2.7 | -7.4 | -4.6 | -7.1 | -6.4 | -4.3 | -4.7 | -5.1 | -5.6 | -6.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6.2 | -7.8 | -2.4 | -6.8 | -6.8 | -3.8 | -4.7 | -5.2 | -5.7 | -6.2 |
| WACC, % | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -21.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -6 | |||||||||
| Terminal Value | -216 | |||||||||
| Present Terminal Value | -170 | |||||||||
| Enterprise Value | -192 | |||||||||
| Net Debt | -3 | |||||||||
| Equity Value | -189 | |||||||||
| Diluted Shares Outstanding, MM | 17 | |||||||||
| Equity Value Per Share | -11.22 |
What You Will Get
- Genuine Biomerica Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Biomerica, Inc. (BMRA).
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates to suit your analysis.
- Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on Biomerica’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario testing, and thorough projections.
- Efficient and Precise: Avoid starting from scratch while ensuring accuracy and adaptability in your financial models.
Key Features
- Comprehensive DCF Model: Features detailed unlevered and levered DCF valuation frameworks tailored for Biomerica, Inc. (BMRA).
- WACC Analysis Tool: Ready-to-use Weighted Average Cost of Capital calculator with adjustable parameters.
- Customizable Forecast Inputs: Easily alter growth projections, capital investments, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency metrics specific to Biomerica, Inc. (BMRA).
- Interactive Dashboard and Visuals: Graphical representations highlight essential valuation indicators for straightforward interpretation.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Biomerica, Inc.'s preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation outcomes.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Biomerica, Inc. (BMRA)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Biomerica, Inc. (BMRA).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Biomerica’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable foundations for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Biomerica, Inc. (BMRA).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Biomerica, Inc. (BMRA) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Biomerica, Inc. (BMRA).
- Consultants: Deliver professional valuation insights regarding Biomerica, Inc. (BMRA) to clients quickly and accurately.
- Business Owners: Understand how companies like Biomerica, Inc. (BMRA) are valued to guide your own strategic decisions.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Biomerica, Inc. (BMRA).
What the Template Contains
- Preloaded BMRA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.